Quiz

Article

Clinical Quiz: Pediatric Acne Treatment Recommendations

Author(s):

In recognition of the Pre-AAD 2024 meeting, take our quiz based on Society for Pediatric Dermatology resources.

Clinical Quiz: Pediatric Acne Treatment Recommendations

A number of patient populations have been subject to greater and more variable opportunities in their care due to the recent boom of dermatologic treatment breakthroughs. Chief among those populations are pediatric and adolescent acne patients, who represent a notable majority of those affected by clinical-grade cases of the skin condition.

In recognition of the Society for Pediatric Dermatology (SPD) 2024 Pre-AAD Meeting in San Diego, CA, this year, this latest HCPLive Clinical Quiz tests readers’ knowledge on the SPD’s recommended strategies for pediatric and adolescent acne management. The 5-question quiz is based on recommendations from the society’s Patient Perspectives handout, originally published in Pediatric Dermatology.

How would you fare in treating young patients with acne? Take the quiz below!

What is the recommended initial treatment for mild acne?


Reference

  1. Aggarwal S, Cyrulnik A, Ilyas E, Stein S, et al. Society for Pediatric Dermatology. Patient Perspectives: Acne Information. Pediatric Dermatology: Vol. 31, No. 6 (2014). https://pedsderm.net/site/assets/files/1028/spd_acne_long_updated.pdf
Related Videos
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
Wei Zhang, MD, PhD: Naltrexone’s GI, Liver Safety for Alcohol Use Disorder Treatment
© 2024 MJH Life Sciences

All rights reserved.